Structural Heart Devices Market Size, Share and Growth Outlook 2026: By Product Type, By Application, By End-User, Companies to 2034
The global Structural Heart Devices Market size is forecast to increase from $9.13 Billion in 2026 to $18.46 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034.
The Structural Heart Devices market report provides detailed analysis and outlook of Structural Heart Devices segments including By Product Type (Repair Devices, Occluders, Annuloplasty Devices, Valvuloplasty Devices, Replacement Devices, Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Mechanical Heart Valves, Tissue Heart Valves, Other Devices, Left Atrial Appendage Closure (LAAC)), By Application (Aortic Valve Stenosis, Mitral Regurgitation, Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defects (VSD)), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs)) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Structural Heart Devices & TAVR Industry Overview
Earlier Intervention Strategies and Expanding Clinical Evidence Continue to Transform Structural Heart Care
The global structural heart devices and transcatheter aortic valve replacement (TAVR) industry continues to evolve rapidly as clinical practice shifts toward earlier diagnosis, proactive intervention, and minimally invasive treatment approaches for valvular heart disease. Technological advancements in transcatheter valve systems, procedural imaging, patient selection algorithms, and long-term durability assessment have expanded the use of structural heart interventions across broader patient populations. Growing evidence supporting improved clinical outcomes, reduced procedural risk, and enhanced quality of life is accelerating the adoption of transcatheter therapies for patients with aortic stenosis, mitral regurgitation, and other structural cardiac conditions. Simultaneously, healthcare providers are increasingly leveraging digital technologies and data-driven decision support tools to optimize referral pathways and reduce disparities in access to advanced cardiac care.
Long-Term Clinical Evidence Strengthens the Position of Transcatheter Valve Therapies
The continued generation of long-term clinical data remains a major driver of adoption across the structural heart market. Manufacturers are increasingly focused on demonstrating superior valve performance, durability, and patient outcomes across diverse patient populations. Recent clinical findings have reinforced the expanding role of TAVR in complex anatomical settings, particularly among patients with small aortic annuli. Medtronic's three-year results from the SMART trial, presented as the largest international head-to-head comparison of TAVR systems, demonstrated superior valve performance and clinical outcomes for the Evolut™ platform compared with surgical aortic valve replacement in this patient population. At the same time, broader market growth continues to be supported by evolving clinical practice patterns emphasizing earlier intervention and proactive disease management strategies for severe aortic stenosis.
Digital Health Integration and Earlier Disease Detection Expand Treatment Access
The structural heart industry is increasingly adopting digital health technologies and artificial intelligence platforms to improve patient identification, referral efficiency, and treatment equity. Healthcare providers are recognizing that delayed diagnosis and referral remain major barriers to optimal outcomes in valvular heart disease. Edwards Lifesciences has reported continued growth in transcatheter valve adoption, attributing increased procedural volumes to earlier patient referrals and expanding clinical evidence supporting long-term valve durability and improved outcomes. Concurrently, artificial intelligence is emerging as an important tool for addressing disparities in structural heart care delivery. Medtronic's ALERT trial demonstrated that AI-enabled clinical notification systems significantly improved evaluation rates and increased timely valve interventions among patients with aortic stenosis and mitral regurgitation, particularly within underserved populations. These developments underscore the broader transformation of structural heart care toward earlier intervention, precision patient identification, and digitally enabled treatment pathways.
Structural Heart Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Structural Heart Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, JenaValve Technology, Inc., Biomerics LLC, CryoLife, Inc. (Artivion, Inc.), Lepu Medical Technology Co., Ltd., Microport Scientific Corporation. The Structural Heart Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Structural Heart Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Structural Heart Devices industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, JenaValve Technology, Inc., Biomerics LLC, CryoLife, Inc. (Artivion, Inc.), Lepu Medical Technology Co., Ltd., Microport Scientific Corporation. The Structural Heart Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Structural Heart Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Structural Heart Devices market remains one of the strongest-performing segments in the country.
The US Structural Heart Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Structural Heart Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Structural Heart Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Structural Heart Devices markets
Canada's strong Structural Heart Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Structural Heart Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Structural Heart Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Structural Heart Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Structural Heart Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Structural Heart Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Structural Heart Devices market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Structural Heart Devices sales through 2034
France Structural Heart Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Structural Heart Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Structural Heart Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Structural Heart Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Structural Heart Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Structural Heart Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Structural Heart Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Structural Heart Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Structural Heart Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Structural Heart Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Structural Heart Devices Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Structural Heart Devices Market Segmentation
By Product Type
Repair Devices
Occluders
Annuloplasty Devices
Valvuloplasty Devices
Replacement Devices
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Mechanical Heart Valves
Tissue Heart Valves
Other Devices
Left Atrial Appendage Closure (LAAC)
By Application
Aortic Valve Stenosis
Mitral Regurgitation
Atrial Septal Defect (ASD)
Patent Foramen Ovale (PFO)
Ventricular Septal Defects (VSD)
By End-User
Hospitals
Ambulatory Surgical Centers (ASCs)
Leading Companies in Structural Heart Devices Industry (2026)
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
LivaNova PLC
JenaValve Technology, Inc.
Biomerics LLC
CryoLife, Inc. (Artivion, Inc.)
Lepu Medical Technology Co., Ltd.
Microport Scientific Corporation
Countries Included
The Structural Heart Devices market report provides detailed analysis and outlook of Structural Heart Devices segments including By Product Type (Repair Devices, Occluders, Annuloplasty Devices, Valvuloplasty Devices, Replacement Devices, Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Mechanical Heart Valves, Tissue Heart Valves, Other Devices, Left Atrial Appendage Closure (LAAC)), By Application (Aortic Valve Stenosis, Mitral Regurgitation, Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defects (VSD)), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs)) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Structural Heart Devices & TAVR Industry Overview
Earlier Intervention Strategies and Expanding Clinical Evidence Continue to Transform Structural Heart Care
The global structural heart devices and transcatheter aortic valve replacement (TAVR) industry continues to evolve rapidly as clinical practice shifts toward earlier diagnosis, proactive intervention, and minimally invasive treatment approaches for valvular heart disease. Technological advancements in transcatheter valve systems, procedural imaging, patient selection algorithms, and long-term durability assessment have expanded the use of structural heart interventions across broader patient populations. Growing evidence supporting improved clinical outcomes, reduced procedural risk, and enhanced quality of life is accelerating the adoption of transcatheter therapies for patients with aortic stenosis, mitral regurgitation, and other structural cardiac conditions. Simultaneously, healthcare providers are increasingly leveraging digital technologies and data-driven decision support tools to optimize referral pathways and reduce disparities in access to advanced cardiac care.
Long-Term Clinical Evidence Strengthens the Position of Transcatheter Valve Therapies
The continued generation of long-term clinical data remains a major driver of adoption across the structural heart market. Manufacturers are increasingly focused on demonstrating superior valve performance, durability, and patient outcomes across diverse patient populations. Recent clinical findings have reinforced the expanding role of TAVR in complex anatomical settings, particularly among patients with small aortic annuli. Medtronic's three-year results from the SMART trial, presented as the largest international head-to-head comparison of TAVR systems, demonstrated superior valve performance and clinical outcomes for the Evolut™ platform compared with surgical aortic valve replacement in this patient population. At the same time, broader market growth continues to be supported by evolving clinical practice patterns emphasizing earlier intervention and proactive disease management strategies for severe aortic stenosis.
Digital Health Integration and Earlier Disease Detection Expand Treatment Access
The structural heart industry is increasingly adopting digital health technologies and artificial intelligence platforms to improve patient identification, referral efficiency, and treatment equity. Healthcare providers are recognizing that delayed diagnosis and referral remain major barriers to optimal outcomes in valvular heart disease. Edwards Lifesciences has reported continued growth in transcatheter valve adoption, attributing increased procedural volumes to earlier patient referrals and expanding clinical evidence supporting long-term valve durability and improved outcomes. Concurrently, artificial intelligence is emerging as an important tool for addressing disparities in structural heart care delivery. Medtronic's ALERT trial demonstrated that AI-enabled clinical notification systems significantly improved evaluation rates and increased timely valve interventions among patients with aortic stenosis and mitral regurgitation, particularly within underserved populations. These developments underscore the broader transformation of structural heart care toward earlier intervention, precision patient identification, and digitally enabled treatment pathways.
Structural Heart Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Structural Heart Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, JenaValve Technology, Inc., Biomerics LLC, CryoLife, Inc. (Artivion, Inc.), Lepu Medical Technology Co., Ltd., Microport Scientific Corporation. The Structural Heart Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Structural Heart Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Structural Heart Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Structural Heart Devices companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Structural Heart Devices markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Structural Heart Devices industry include- Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, JenaValve Technology, Inc., Biomerics LLC, CryoLife, Inc. (Artivion, Inc.), Lepu Medical Technology Co., Ltd., Microport Scientific Corporation. The Structural Heart Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Structural Heart Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Structural Heart Devices market remains one of the strongest-performing segments in the country.
The US Structural Heart Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Structural Heart Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Structural Heart Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Structural Heart Devices markets
Canada's strong Structural Heart Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Structural Heart Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Structural Heart Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Structural Heart Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Structural Heart Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Structural Heart Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Structural Heart Devices market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Structural Heart Devices sales through 2034
France Structural Heart Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Structural Heart Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Structural Heart Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Structural Heart Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Structural Heart Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Structural Heart Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Structural Heart Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Structural Heart Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Structural Heart Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Structural Heart Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Structural Heart Devices Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Structural Heart Devices Market Segmentation
By Product Type
Repair Devices
Occluders
Annuloplasty Devices
Valvuloplasty Devices
Replacement Devices
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Mechanical Heart Valves
Tissue Heart Valves
Other Devices
Left Atrial Appendage Closure (LAAC)
By Application
Aortic Valve Stenosis
Mitral Regurgitation
Atrial Septal Defect (ASD)
Patent Foramen Ovale (PFO)
Ventricular Septal Defects (VSD)
By End-User
Hospitals
Ambulatory Surgical Centers (ASCs)
Leading Companies in Structural Heart Devices Industry (2026)
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
LivaNova PLC
JenaValve Technology, Inc.
Biomerics LLC
CryoLife, Inc. (Artivion, Inc.)
Lepu Medical Technology Co., Ltd.
Microport Scientific Corporation
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Structural Heart Devices Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Structural Heart Devices Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL STRUCTURAL HEART DEVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Structural Heart Devices Markets in 2026
3.2. Global Historic and Forecast Structural Heart Devices Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Structural Heart Devices Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Structural Heart Devices Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Structural Heart Devices Value Chain
CHAPTER 4- STRUCTURAL HEART DEVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Structural Heart Devices Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- STRUCTURAL HEART DEVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Repair Devices
Occluders
Annuloplasty Devices
Valvuloplasty Devices
Replacement Devices
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Mechanical Heart Valves
Tissue Heart Valves
Other Devices
Left Atrial Appendage Closure (LAAC)
By Application
Aortic Valve Stenosis
Mitral Regurgitation
Atrial Septal Defect (ASD)
Patent Foramen Ovale (PFO)
Ventricular Septal Defects (VSD)
By End-User
Hospitals
Ambulatory Surgical Centers (ASCs)
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Structural Heart Devices Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Structural Heart Devices Market Trends and Growth Opportunities to 2034
7.5. North America Structural Heart Devices Market Size Outlook by Type
7.6. North America Structural Heart Devices Market Size Outlook by Application
7.7. North America Structural Heart Devices Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Structural Heart Devices Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Structural Heart Devices Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Structural Heart Devices Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Structural Heart Devices Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Structural Heart Devices Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Structural Heart Devices Companies
CHAPTER 8- EUROPE STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Structural Heart Devices Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Structural Heart Devices Market Trends and Growth Opportunities to 2034
8.5. Europe Structural Heart Devices Market Size Outlook by Type
8.6. Europe Structural Heart Devices Market Size Outlook by Application
8.7. Europe Structural Heart Devices Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Structural Heart Devices Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Structural Heart Devices Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Structural Heart Devices Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Structural Heart Devices Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Structural Heart Devices Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Structural Heart Devices Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Structural Heart Devices Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Structural Heart Devices Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Structural Heart Devices Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Structural Heart Devices Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Structural Heart Devices Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Structural Heart Devices Companies
CHAPTER 9- ASIA PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Structural Heart Devices Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Structural Heart Devices Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Structural Heart Devices Market Size Outlook by Type
9.6. Asia Pacific Structural Heart Devices Market Size Outlook by Application
9.7. Asia Pacific Structural Heart Devices Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Structural Heart Devices Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Structural Heart Devices Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Structural Heart Devices Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Structural Heart Devices Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Structural Heart Devices Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Structural Heart Devices Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Structural Heart Devices Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Structural Heart Devices Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Structural Heart Devices Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Structural Heart Devices Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Structural Heart Devices Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Structural Heart Devices Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Structural Heart Devices Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Structural Heart Devices Market Trends and Growth Opportunities to 2034
10.5. South and Central America Structural Heart Devices Market Size Outlook by Type
10.6. South and Central America Structural Heart Devices Market Size Outlook by Application
10.7. South and Central America Structural Heart Devices Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Structural Heart Devices Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Structural Heart Devices Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Structural Heart Devices Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Structural Heart Devices Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Structural Heart Devices Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Structural Heart Devices Companies
CHAPTER 11- MIDDLE EAST AND AFRICA STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Structural Heart Devices Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Structural Heart Devices Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Structural Heart Devices Market Size Outlook by Type
11.6. Middle East and Africa Structural Heart Devices Market Size Outlook by Application
11.7. Middle East and Africa Structural Heart Devices Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Structural Heart Devices Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Structural Heart Devices Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Structural Heart Devices Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Structural Heart Devices Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Structural Heart Devices Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Structural Heart Devices Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Structural Heart Devices Industry
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
LivaNova PLC
JenaValve Technology, Inc.
Biomerics LLC
CryoLife, Inc. (Artivion, Inc.)
Lepu Medical Technology Co., Ltd.
Microport Scientific Corporation
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Structural Heart Devices Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Structural Heart Devices Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL STRUCTURAL HEART DEVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Structural Heart Devices Markets in 2026
3.2. Global Historic and Forecast Structural Heart Devices Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Structural Heart Devices Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Structural Heart Devices Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Structural Heart Devices Value Chain
CHAPTER 4- STRUCTURAL HEART DEVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Structural Heart Devices Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- STRUCTURAL HEART DEVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Repair Devices
Occluders
Annuloplasty Devices
Valvuloplasty Devices
Replacement Devices
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Mechanical Heart Valves
Tissue Heart Valves
Other Devices
Left Atrial Appendage Closure (LAAC)
By Application
Aortic Valve Stenosis
Mitral Regurgitation
Atrial Septal Defect (ASD)
Patent Foramen Ovale (PFO)
Ventricular Septal Defects (VSD)
By End-User
Hospitals
Ambulatory Surgical Centers (ASCs)
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Structural Heart Devices Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Structural Heart Devices Market Trends and Growth Opportunities to 2034
7.5. North America Structural Heart Devices Market Size Outlook by Type
7.6. North America Structural Heart Devices Market Size Outlook by Application
7.7. North America Structural Heart Devices Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Structural Heart Devices Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Structural Heart Devices Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Structural Heart Devices Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Structural Heart Devices Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Structural Heart Devices Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Structural Heart Devices Companies
CHAPTER 8- EUROPE STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Structural Heart Devices Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Structural Heart Devices Market Trends and Growth Opportunities to 2034
8.5. Europe Structural Heart Devices Market Size Outlook by Type
8.6. Europe Structural Heart Devices Market Size Outlook by Application
8.7. Europe Structural Heart Devices Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Structural Heart Devices Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Structural Heart Devices Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Structural Heart Devices Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Structural Heart Devices Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Structural Heart Devices Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Structural Heart Devices Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Structural Heart Devices Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Structural Heart Devices Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Structural Heart Devices Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Structural Heart Devices Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Structural Heart Devices Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Structural Heart Devices Companies
CHAPTER 9- ASIA PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Structural Heart Devices Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Structural Heart Devices Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Structural Heart Devices Market Size Outlook by Type
9.6. Asia Pacific Structural Heart Devices Market Size Outlook by Application
9.7. Asia Pacific Structural Heart Devices Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Structural Heart Devices Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Structural Heart Devices Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Structural Heart Devices Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Structural Heart Devices Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Structural Heart Devices Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Structural Heart Devices Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Structural Heart Devices Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Structural Heart Devices Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Structural Heart Devices Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Structural Heart Devices Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Structural Heart Devices Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Structural Heart Devices Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Structural Heart Devices Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Structural Heart Devices Market Trends and Growth Opportunities to 2034
10.5. South and Central America Structural Heart Devices Market Size Outlook by Type
10.6. South and Central America Structural Heart Devices Market Size Outlook by Application
10.7. South and Central America Structural Heart Devices Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Structural Heart Devices Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Structural Heart Devices Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Structural Heart Devices Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Structural Heart Devices Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Structural Heart Devices Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Structural Heart Devices Companies
CHAPTER 11- MIDDLE EAST AND AFRICA STRUCTURAL HEART DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Structural Heart Devices Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Structural Heart Devices Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Structural Heart Devices Market Size Outlook by Type
11.6. Middle East and Africa Structural Heart Devices Market Size Outlook by Application
11.7. Middle East and Africa Structural Heart Devices Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Structural Heart Devices Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Structural Heart Devices Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Structural Heart Devices Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Structural Heart Devices Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Structural Heart Devices Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Structural Heart Devices Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Structural Heart Devices Industry
Edwards Lifesciences Corporation
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
LivaNova PLC
JenaValve Technology, Inc.
Biomerics LLC
CryoLife, Inc. (Artivion, Inc.)
Lepu Medical Technology Co., Ltd.
Microport Scientific Corporation
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
